FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149322454> ?p ?o ?g. }

• W2149322454 abstract "Galectin-3 (Gal-3) participates in different mechanisms involved in atherothrombosis, such as inflammation, proliferation, or macrophage chemotaxis. Thus, there have been committed intensive efforts to elucidate the function of Gal-3 in cardiovascular (CV) diseases. The role of Gal-3 as a circulating biomarker has been demonstrated in patients with heart failure, but its importance as a biomarker in atherothrombosis is still unknown.Because Gal-3 is involved in monocyte-to-macrophage transition, we used fresh isolated monocytes and the in vitro model of macrophage differentiation of THP-1 cells stimulated with phorbol myristate acetate (PMA). Gal-3 release is increased by PMA in human monocytes and macrophages, a process involving exosomes and regulated by reactive oxygen species/NADPH oxidase activity. In asymptomatic subjects (n=199), Gal-3 plasma levels are correlated with NADPH oxidase activity in peripheral blood mononuclear cells (r=0.476; P<0.001) and carotid intima-media thickness (r=0.438; P<0.001), a surrogate marker of atherosclerosis. Accordingly, Gal-3 plasma concentrations are increased in patients with carotid atherosclerosis (n=158), compared to control subjects (n=115; 14.3 [10.7 to 16.9] vs. 10.4 [8.6 to 12.5] ng/mL; P<0.001). Finally, on a 5-year follow-up study in patients with peripheral artery disease, Gal-3 concentrations are significantly and independently associated with an increased risk for CV mortality (hazard ratio=2.24, 95% confidence interval: 1.06 to 4.73, P<0.05).Gal-3 extracellular levels could reflect key underlying mechanisms involved in atherosclerosis etiology, development, and plaque rupture, such as inflammation, infiltration of circulating cells and oxidative stress. Moreover, circulating Gal-3 concentrations are associated with clinical outcomes in patients with atherothrombosis." @default.
• W2149322454 created "2016-06-24" @default.
• W2149322454 creator A5005804630 @default.
• W2149322454 creator A5007753934 @default.
• W2149322454 creator A5027851341 @default.
• W2149322454 creator A5039337569 @default.
• W2149322454 creator A5041104466 @default.
• W2149322454 creator A5041382502 @default.
• W2149322454 creator A5050488351 @default.
• W2149322454 creator A5061782816 @default.
• W2149322454 creator A5063245254 @default.
• W2149322454 creator A5064747640 @default.
• W2149322454 creator A5073096633 @default.
• W2149322454 creator A5090805967 @default.
• W2149322454 date "2014-08-15" @default.
• W2149322454 modified "2023-10-18" @default.
• W2149322454 title "Galectin‐3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis" @default.
• W2149322454 cites W1789328091 @default.
• W2149322454 cites W1874379912 @default.
• W2149322454 cites W1877686344 @default.
• W2149322454 cites W1980509119 @default.
• W2149322454 cites W1983908302 @default.
• W2149322454 cites W1993481526 @default.
• W2149322454 cites W1997544440 @default.
• W2149322454 cites W1998433528 @default.
• W2149322454 cites W2009135351 @default.
• W2149322454 cites W2014097940 @default.
• W2149322454 cites W2023449463 @default.
• W2149322454 cites W2035506819 @default.
• W2149322454 cites W2039669614 @default.
• W2149322454 cites W2042751187 @default.
• W2149322454 cites W2043586033 @default.
• W2149322454 cites W2050865773 @default.
• W2149322454 cites W2069182108 @default.
• W2149322454 cites W2072751592 @default.
• W2149322454 cites W2096960616 @default.
• W2149322454 cites W2105670393 @default.
• W2149322454 cites W2109257372 @default.
• W2149322454 cites W2109698138 @default.
• W2149322454 cites W2111778115 @default.
• W2149322454 cites W2114993988 @default.
• W2149322454 cites W2123248199 @default.
• W2149322454 cites W2142280282 @default.
• W2149322454 cites W2142633227 @default.
• W2149322454 cites W2143795945 @default.
• W2149322454 cites W2145836265 @default.
• W2149322454 cites W2156872975 @default.
• W2149322454 cites W2161321429 @default.
• W2149322454 cites W2162704471 @default.
• W2149322454 doi "https://doi.org/10.1161/jaha.114.000785" @default.
• W2149322454 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4310363" @default.
• W2149322454 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25095870" @default.
• W2149322454 hasPublicationYear "2014" @default.
• W2149322454 type Work @default.
• W2149322454 sameAs 2149322454 @default.
• W2149322454 citedByCount "109" @default.
• W2149322454 countsByYear W21493224542015 @default.
• W2149322454 countsByYear W21493224542016 @default.
• W2149322454 countsByYear W21493224542017 @default.
• W2149322454 countsByYear W21493224542018 @default.
• W2149322454 countsByYear W21493224542019 @default.
• W2149322454 countsByYear W21493224542020 @default.
• W2149322454 countsByYear W21493224542021 @default.
• W2149322454 countsByYear W21493224542022 @default.
• W2149322454 countsByYear W21493224542023 @default.
• W2149322454 crossrefType "journal-article" @default.
• W2149322454 hasAuthorship W2149322454A5005804630 @default.
• W2149322454 hasAuthorship W2149322454A5007753934 @default.
• W2149322454 hasAuthorship W2149322454A5027851341 @default.
• W2149322454 hasAuthorship W2149322454A5039337569 @default.
• W2149322454 hasAuthorship W2149322454A5041104466 @default.
• W2149322454 hasAuthorship W2149322454A5041382502 @default.
• W2149322454 hasAuthorship W2149322454A5050488351 @default.
• W2149322454 hasAuthorship W2149322454A5061782816 @default.
• W2149322454 hasAuthorship W2149322454A5063245254 @default.
• W2149322454 hasAuthorship W2149322454A5064747640 @default.
• W2149322454 hasAuthorship W2149322454A5073096633 @default.
• W2149322454 hasAuthorship W2149322454A5090805967 @default.
• W2149322454 hasBestOaLocation W21493224541 @default.
• W2149322454 hasConcept C126322002 @default.
• W2149322454 hasConcept C134018914 @default.
• W2149322454 hasConcept C203014093 @default.
• W2149322454 hasConcept C207103383 @default.
• W2149322454 hasConcept C2776151105 @default.
• W2149322454 hasConcept C2776336362 @default.
• W2149322454 hasConcept C2776914184 @default.
• W2149322454 hasConcept C2777910003 @default.
• W2149322454 hasConcept C2779719074 @default.
• W2149322454 hasConcept C2781184567 @default.
• W2149322454 hasConcept C2781197716 @default.
• W2149322454 hasConcept C44249647 @default.
• W2149322454 hasConcept C55493867 @default.
• W2149322454 hasConcept C71924100 @default.
• W2149322454 hasConcept C86803240 @default.
• W2149322454 hasConceptScore W2149322454C126322002 @default.
• W2149322454 hasConceptScore W2149322454C134018914 @default.
• W2149322454 hasConceptScore W2149322454C203014093 @default.
• W2149322454 hasConceptScore W2149322454C207103383 @default.
• W2149322454 hasConceptScore W2149322454C2776151105 @default.
• W2149322454 hasConceptScore W2149322454C2776336362 @default.

• next